Precision oncology: separating the wheat from the chaff

about

Precision oncology: separating the wheat from the chaff

Item

http://www.wikidata.org/entity/Q58698377

description

scientific article published on 30 October 2018

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в жовтні 2018

@uk

name

Precision oncology: separating the wheat from the chaff

@en

Precision oncology: separating the wheat from the chaff

@nl

type

Item

label

Precision oncology: separating the wheat from the chaff

@en

Precision oncology: separating the wheat from the chaff

@nl

prefLabel

Precision oncology: separating the wheat from the chaff

@en

Precision oncology: separating the wheat from the chaff

@nl

P1476

Precision oncology: separating the wheat from the chaff

@en

P2093

Jordi Remon

http://www.w3.org/2001/XMLSchema#string

Rodrigo Dienstmann

http://www.w3.org/2001/XMLSchema#string

P2860

Mutational heterogeneity in cancer and the search for new cancer-associated genes

Next-generation sequencing to guide cancer therapy

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial.

Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial.

First-line crizotinib versus chemotherapy in ALK-positive lung cancer.

Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): analysis of overall survival data from two randomised, phase 3 trials.

Vemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 Mutations.

Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma

Discovery and saturation analysis of cancer genes across 21 tumour types

Routine multiplex mutational profiling of melanomas enables enrollment in genotype-driven therapeutic trials

P304

e000446

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/ESMOOPEN-2018-000446

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-10-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30425845

http://www.w3.org/2001/XMLSchema#string

P921

Avati mirĩ

P932

6212683

http://www.w3.org/2001/XMLSchema#string